Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.3% | -23.3% | 1,564.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -55.9% | -15.3% | 6.7% | -1,631.7% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -58.5% | -18.8% | 4.5% | -1,648% |
| EPS Diluted | -3 | -1.12 | 0.35 | -7.74 |
| % Growth | -167.9% | -420% | 104.5% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |